Continued Significant Improvement in Skin Appearance Observed in StudySubject’s Disease Classification Improved from “Severe” ...
Quoin Pharmaceuticals (QNRX) announces interim clinical data from its ongoing Investigator Pediatric Netherton Syndrome clinical study. The ...
Jan. 14, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today ...
ASHBURN, Va. - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company with a market capitalization of $2.89 million, announced positive... Quoin Pharmaceutica ...
After hours: 10 January at 19:30:34 GMT-5 ...
UnitedHealth Group's headquarters building is seen in Minnetonka, Minnesota, U.S. in this handout picture taken in 2019. UnitedHealth Group/Handout via REUTERS/File Photo Analysts and investors ...
Michael McLaren appointed Chairman of Safe & Green. MIAMI, FL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. ...
Infinity Pharmaceuticals Inc. 0.00% $90.76 ...
After hours: January 14 at 5:06:12 PM EST Loading Chart for SHPH ...